• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在西班牙,淋巴组织病理学的临床表现或组织学表现是否随着时间的推移而存在显著差异?

Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?

机构信息

Servicio de Oncología Médica, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.

出版信息

Clin Transl Oncol. 2012 May;14(5):386-90. doi: 10.1007/s12094-012-0813-3.

DOI:10.1007/s12094-012-0813-3
PMID:22551546
Abstract

INTRODUCTION

Little data is available concerning variations in the clinical characteristics of lymphoid neoplasms at presentation. We decided to investigate whether any variations in these characteristics had occurred in Spain during the last few years.

MATERIALS AND METHODS

The GOTEL group database is an archive of all new lymphoma cases, regardless of their histological subtype, diagnosed in the hospitals within the group. An analysis was made of all the records between 1 January 1999 and 1 January 2009. Though the number of hospitals submitting data has changed over the course of time, data were provided by 26 hospitals from 16 Spanish provinces.

RESULTS

A total of 3651 cases of lymphoma were recorded during this period. Grouped by clinical features, 42.8% (1561 patients) had low-grade lymphoma, 30.4% (1110 patients) intermediate-grade lymphoma and 15.2% (556 patients) Hodgkin's lymphoma; 208 patients had T lymphoma (5.7%), 111 patients high-grade lymphoma (3%) and 105 patients (2.9%) suffered lymphomas that were difficult to classify. A total of 6.3% of the diagnoses (231 patients) were made prior to 1999, 29.5% between 2000 and 2001, 25.7% between 2002 and 2003, 19.7% between 2004 and 2005, 11.2% between 2006 and 2007, and there were 200 entries from 2008 to the close of the study period, corresponding to 1.5% of the complete database. The median age at diagnosis was 60 (range 7-105 years), by percentiles: 25 corresponded to 44 years old, 50 to 60 years old and 75 to 71. Distribution by gender was 53.1% male and 46.9% female. An analysis was made of all the clinical variables collected, comparing their behaviour during the different diagnostic periods. The periods, gender, ECOG, stage, LDH, ß2 microglobulin, Hodgkin's or non- Hodgkin's type neoplasm, B lymphoma vs. Hodgkin's, NK or T, nodal or extra-nodal origin, median age at diagnosis and histological type by region of origin did not show any statistically significant differences in their distribution over the course of time.

CONCLUSION

In our experience, there are no significant variations in clinical presentation or histological type in lymphomas diagnosed over the course of time in Spain.

摘要

简介

关于淋巴肿瘤在初诊时的临床特征的变化,目前仅有少量数据。因此我们决定研究一下在过去几年里,西班牙是否出现了这些特征的变化。

材料与方法

GOTEL 组数据库是所有新诊断的淋巴瘤病例的档案,无论其组织学亚型如何,都包含在组内医院内。对 1999 年 1 月 1 日至 2009 年 1 月 1 日之间的所有记录进行了分析。虽然提交数据的医院数量随着时间的推移而变化,但有来自西班牙 16 个省的 26 家医院提供了数据。

结果

在此期间共记录了 3651 例淋巴瘤。根据临床特征分组,42.8%(1561 例)为低级别淋巴瘤,30.4%(1110 例)为中级别淋巴瘤,15.2%(556 例)为霍奇金淋巴瘤;208 例为 T 淋巴瘤(5.7%),111 例为高级别淋巴瘤(3%),105 例(2.9%)为难分类淋巴瘤。诊断前在 1999 年之前的占 6.3%(231 例),2000 年至 2001 年为 29.5%,2002 年至 2003 年为 25.7%,2004 年至 2005 年为 19.7%,2006 年至 2007 年为 11.2%,2008 年至研究结束时有 200 例,占完整数据库的 1.5%。中位诊断年龄为 60 岁(7-105 岁),按百分位数:25%对应 44 岁,50%对应 60 岁,75%对应 71 岁。性别分布为 53.1%为男性,46.9%为女性。分析了收集的所有临床变量,比较了它们在不同诊断期的变化。结果显示,不同诊断期、性别、ECOG、分期、LDH、β2 微球蛋白、霍奇金氏或非霍奇金氏肿瘤、B 细胞淋巴瘤与霍奇金氏淋巴瘤、NK 或 T 细胞、结内或结外起源、诊断时的中位年龄和组织学类型在不同时间的分布上没有统计学差异。

结论

根据我们的经验,在西班牙,随时间推移诊断出的淋巴瘤在临床表现或组织学类型上没有显著变化。

相似文献

1
Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?在西班牙,淋巴组织病理学的临床表现或组织学表现是否随着时间的推移而存在显著差异?
Clin Transl Oncol. 2012 May;14(5):386-90. doi: 10.1007/s12094-012-0813-3.
2
RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group.RELINF:西班牙淋巴肿瘤的前瞻性流行病学注册研究。GELTAMO 小组的一个项目。
Ann Hematol. 2020 Apr;99(4):799-808. doi: 10.1007/s00277-020-03918-6. Epub 2020 Feb 20.
3
The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan.台湾单一家医院 303 例依据世界卫生组织分类系统分类的恶性淋巴瘤的临床病理分析。
Ann Hematol. 2010 Jun;89(6):553-62. doi: 10.1007/s00277-009-0870-z. Epub 2009 Dec 11.
4
Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.犬淋巴瘤:分类类型、疾病分期、肿瘤亚型、有丝分裂率和治疗与生存的关系。
Vet Pathol. 2013 Sep;50(5):738-48. doi: 10.1177/0300985813478210. Epub 2013 Feb 26.
5
Gastrointestinal lymphomas: pattern of distribution and histological subtypes: 10 years experience in a tertiary centre in South India.胃肠道淋巴瘤:分布模式与组织学亚型:印度南部一家三级中心的10年经验
Indian J Pathol Microbiol. 2011 Oct-Dec;54(4):712-9. doi: 10.4103/0377-4929.91502.
6
[Clinical and prognostic analysis of 101 cases of primary gastrointestinal non-Hodgkin's lymphoma].101例原发性胃肠道非霍奇金淋巴瘤的临床及预后分析
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Apr;21(2):387-91. doi: 10.7534/j.issn.1009-2137.2013.02.026.
7
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.外周T细胞淋巴瘤(不包括间变性大细胞淋巴瘤):来自非霍奇金淋巴瘤分类项目的结果
Ann Oncol. 2002 Jan;13(1):140-9. doi: 10.1093/annonc/mdf033.
8
Vascular endothelial growth factor expression in low and high grade B-cell non-Hodgkin's lymphomas.
Turk Patoloji Derg. 2011;27(3):204-9. doi: 10.5146/tjpath.2011.01076.
9
[Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].[根据世界卫生组织当前的淋巴样肿瘤分类对493例非霍奇金淋巴瘤进行临床和病理重新评估]
Zhonghua Bing Li Xue Za Zhi. 2005 Jan;34(1):22-7.
10
Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.胃肠道非霍奇金淋巴瘤:基于人群的发病率、地理分布、临床病理表现特征及预后分析。丹麦淋巴瘤研究组
J Clin Oncol. 1994 Aug;12(8):1673-84. doi: 10.1200/JCO.1994.12.8.1673.

引用本文的文献

1
SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022).SEOM-GOTEL 弥漫性大 B 细胞淋巴瘤临床指南(2022 年)。
Clin Transl Oncol. 2023 Sep;25(9):2749-2758. doi: 10.1007/s12094-023-03206-5. Epub 2023 Jun 8.
2
Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry.滤泡性淋巴瘤长期生存患者的治疗影响:一项西班牙淋巴瘤肿瘤学组登记研究。
PLoS One. 2017 May 11;12(5):e0177204. doi: 10.1371/journal.pone.0177204. eCollection 2017.
3
SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma.

本文引用的文献

1
Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.2000-2002 年诊断为淋巴肿瘤的欧洲患者的生存情况:HAEMACARE 项目的结果。
Haematologica. 2011 May;96(5):720-8. doi: 10.3324/haematol.2010.034264. Epub 2011 Feb 17.
2
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project.欧洲形态亚型血液系统恶性肿瘤的发病率:HAEMACARE 项目的结果。
Blood. 2010 Nov 11;116(19):3724-34. doi: 10.1182/blood-2010-05-282632. Epub 2010 Jul 27.
3
Attenuation of the epidemic increase in non-Hodgkin's lymphomas in Spain.
SEOM滤泡性非霍奇金淋巴瘤治疗临床指南
Clin Transl Oncol. 2015 Dec;17(12):1014-9. doi: 10.1007/s12094-015-1437-1. Epub 2015 Nov 19.
西班牙非霍奇金淋巴瘤疫情增长的减弱。
Ann Oncol. 2010 May;21 Suppl 3:iii90-96. doi: 10.1093/annonc/mdq088.
4
Cancer survival in Spain: estimate for nine major cancers.西班牙癌症存活率:九大常见癌症预估。
Ann Oncol. 2010 May;21 Suppl 3:iii21-29. doi: 10.1093/annonc/mdq082.
5
Cancer mortality trends in Spain: 1980-2007.西班牙的癌症死亡率趋势:1980-2007 年。
Ann Oncol. 2010 May;21 Suppl 3:iii14-20. doi: 10.1093/annonc/mdq089.
6
Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).胃肠胰神经内分泌肿瘤(GEP-NETs)发病、治疗模式及预后因素分析:来自西班牙国家癌症登记处(RGETNE)的研究结果。
Ann Oncol. 2010 Sep;21(9):1794-1803. doi: 10.1093/annonc/mdq022. Epub 2010 Feb 5.
7
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).国际淋巴瘤流行病学联盟(InterLymph)病理学工作组提出的用于流行病学研究的淋巴样肿瘤分类。
Blood. 2007 Jul 15;110(2):695-708. doi: 10.1182/blood-2006-11-051672. Epub 2007 Mar 27.
8
Cancer incidence in AIDS patients in Catalonia, Spain.西班牙加泰罗尼亚地区艾滋病患者的癌症发病率。
Eur J Cancer. 2007 Apr;43(6):1085-91. doi: 10.1016/j.ejca.2007.01.028. Epub 2007 Mar 8.
9
Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study.淋巴瘤亚型癌症登记编码的变化:随时间的可靠性以及对监测和研究的相关性
Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):630-8. doi: 10.1158/1055-9965.EPI-05-0549.
10
Historical review of lymphomas.淋巴瘤的历史回顾。
Br J Haematol. 2000 Jun;109(3):466-76. doi: 10.1046/j.1365-2141.2000.01988.x.